Discovery of HIV capsid inhibitors

Artía, Zoraima - Randall, Lía - Corvo, Ileana - Nuenen, Ad - Kootstra, Neeltje - Álvarez, Guzmán

Resumen:

HIV capsid is formed by a single viral protein (CA), which plays an essential role in early as well as later steps of infection1. The correct capsid assembly is essential for HIV infectivity2. The high conservation of the aminoacidic sequence of CA and its high sensitivity to mutations highlights its role in the viral cycle success and supports the research of molecules able to interfere with CA multimerization as possible HIV inhibitors3. In this work we studied 84 compounds selected through a massive virtual screening of molecules capable of interacting with a conserved region of the interface surface between CA monomers. We analyzed the in vitro assembly of recombinant CA in the presence of these compounds, identifying 30 molecules affecting its multimerization. Additionally, using an in cellulo HIV infection model, we identified 4 compounds interfering with viral infection with IC50 values between 3 and 13 μM.

Detalles Bibliográficos
2022
Agencia Nacional de Investigación e Innovación
Imaging learning
HIV
Capsid protein
Antiviral drug discovery
Ciencias Médicas y de la Salud
Medicina Básica
Medicina Química
Ciencias Naturales y Exactas
Ciencias Biológicas
Bioquímica y Biología Molecular
Inglés
Agencia Nacional de Investigación e Innovación
REDI
https://hdl.handle.net/20.500.12381/5284
https://proceedings.science/brazmedchem-2022/papers/discovery-of-hiv-capsid-inhibitors?lang=en
Acceso abierto
Reconocimiento 4.0 Internacional. (CC BY)
_version_ 1875749924915642368
author Artía, Zoraima
author2 Randall, Lía
Corvo, Ileana
Nuenen, Ad
Kootstra, Neeltje
Álvarez, Guzmán
author2_role author
author
author
author
author
author_facet Artía, Zoraima
Randall, Lía
Corvo, Ileana
Nuenen, Ad
Kootstra, Neeltje
Álvarez, Guzmán
author_role author
bitstream.checksum.fl_str_mv a4ce09f01b5dd771727aa05c73851623
3d2ad3d2cad0e327593c966b75d4b5da
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
bitstream.url.fl_str_mv https://redi.anii.org.uy/jspui/bitstream/20.500.12381/5284/2/license.txt
https://redi.anii.org.uy/jspui/bitstream/20.500.12381/5284/1/P%c3%b3ster%20BrazMedChem%202022_%20120x90.pdf
collection REDI
dc.creator.none.fl_str_mv Artía, Zoraima
Randall, Lía
Corvo, Ileana
Nuenen, Ad
Kootstra, Neeltje
Álvarez, Guzmán
dc.date.accessioned.none.fl_str_mv 2025-10-31T13:39:05Z
dc.date.available.none.fl_str_mv 2025-10-31T13:39:05Z
dc.date.issued.none.fl_str_mv 2022-09-25
dc.description.abstract.none.fl_txt_mv HIV capsid is formed by a single viral protein (CA), which plays an essential role in early as well as later steps of infection1. The correct capsid assembly is essential for HIV infectivity2. The high conservation of the aminoacidic sequence of CA and its high sensitivity to mutations highlights its role in the viral cycle success and supports the research of molecules able to interfere with CA multimerization as possible HIV inhibitors3. In this work we studied 84 compounds selected through a massive virtual screening of molecules capable of interacting with a conserved region of the interface surface between CA monomers. We analyzed the in vitro assembly of recombinant CA in the presence of these compounds, identifying 30 molecules affecting its multimerization. Additionally, using an in cellulo HIV infection model, we identified 4 compounds interfering with viral infection with IC50 values between 3 and 13 μM.
dc.description.sponsorship.none.fl_txt_mv Agencia Nacional de Investigación e Innovación
dc.identifier.anii.es.fl_str_mv FCE_3_2022_1_172494
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12381/5284
dc.identifier.url.none.fl_str_mv https://proceedings.science/brazmedchem-2022/papers/discovery-of-hiv-capsid-inhibitors?lang=en
dc.language.iso.none.fl_str_mv eng
dc.relation.none.fl_str_mv https://hdl.handle.net/20.500.12381/5273
https://hdl.handle.net/20.500.12381/5280
https://hdl.handle.net/20.500.12381/5285
https://hdl.handle.net/20.500.12381/5286
https://hdl.handle.net/20.500.12381/5305
dc.rights.*.fl_str_mv Acceso abierto
dc.rights.license.none.fl_str_mv Reconocimiento 4.0 Internacional. (CC BY)
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.source.es.fl_str_mv 10th BrazMedChem. Poços de Caldas, Minas Gerais, Brasil. 2022
dc.source.none.fl_str_mv reponame:REDI
instname:Agencia Nacional de Investigación e Innovación
instacron:Agencia Nacional de Investigación e Innovación
dc.subject.anii.none.fl_str_mv Ciencias Médicas y de la Salud
Medicina Básica
Medicina Química
Ciencias Naturales y Exactas
Ciencias Biológicas
Bioquímica y Biología Molecular
dc.subject.es.fl_str_mv Imaging learning
HIV
Capsid protein
Antiviral drug discovery
dc.title.none.fl_str_mv Discovery of HIV capsid inhibitors
dc.type.es.fl_str_mv Documento de conferencia
dc.type.none.fl_str_mv info:eu-repo/semantics/conferenceObject
dc.type.version.es.fl_str_mv Publicado
dc.type.version.none.fl_str_mv info:eu-repo/semantics/publishedVersion
description HIV capsid is formed by a single viral protein (CA), which plays an essential role in early as well as later steps of infection1. The correct capsid assembly is essential for HIV infectivity2. The high conservation of the aminoacidic sequence of CA and its high sensitivity to mutations highlights its role in the viral cycle success and supports the research of molecules able to interfere with CA multimerization as possible HIV inhibitors3. In this work we studied 84 compounds selected through a massive virtual screening of molecules capable of interacting with a conserved region of the interface surface between CA monomers. We analyzed the in vitro assembly of recombinant CA in the presence of these compounds, identifying 30 molecules affecting its multimerization. Additionally, using an in cellulo HIV infection model, we identified 4 compounds interfering with viral infection with IC50 values between 3 and 13 μM.
eu_rights_str_mv openAccess
format conferenceObject
id REDI_4586a5a9d9b957f160b2af631b5fc643
identifier_str_mv FCE_3_2022_1_172494
instacron_str Agencia Nacional de Investigación e Innovación
institution Agencia Nacional de Investigación e Innovación
instname_str Agencia Nacional de Investigación e Innovación
language eng
network_acronym_str REDI
network_name_str REDI
oai_identifier_str oai:redi.anii.org.uy:20.500.12381/5284
publishDate 2022
reponame_str REDI
repository.mail.fl_str_mv jmaldini@anii.org.uy
repository.name.fl_str_mv REDI - Agencia Nacional de Investigación e Innovación
repository_id_str 9421
rights_invalid_str_mv Reconocimiento 4.0 Internacional. (CC BY)
Acceso abierto
spelling Reconocimiento 4.0 Internacional. (CC BY)Acceso abiertoinfo:eu-repo/semantics/openAccess2025-10-31T13:39:05Z2025-10-31T13:39:05Z2022-09-25https://hdl.handle.net/20.500.12381/5284FCE_3_2022_1_172494https://proceedings.science/brazmedchem-2022/papers/discovery-of-hiv-capsid-inhibitors?lang=enHIV capsid is formed by a single viral protein (CA), which plays an essential role in early as well as later steps of infection1. The correct capsid assembly is essential for HIV infectivity2. The high conservation of the aminoacidic sequence of CA and its high sensitivity to mutations highlights its role in the viral cycle success and supports the research of molecules able to interfere with CA multimerization as possible HIV inhibitors3. In this work we studied 84 compounds selected through a massive virtual screening of molecules capable of interacting with a conserved region of the interface surface between CA monomers. We analyzed the in vitro assembly of recombinant CA in the presence of these compounds, identifying 30 molecules affecting its multimerization. Additionally, using an in cellulo HIV infection model, we identified 4 compounds interfering with viral infection with IC50 values between 3 and 13 μM.Agencia Nacional de Investigación e Innovaciónenghttps://hdl.handle.net/20.500.12381/5273https://hdl.handle.net/20.500.12381/5280https://hdl.handle.net/20.500.12381/5285https://hdl.handle.net/20.500.12381/5286https://hdl.handle.net/20.500.12381/530510th BrazMedChem. Poços de Caldas, Minas Gerais, Brasil. 2022reponame:REDIinstname:Agencia Nacional de Investigación e Innovacióninstacron:Agencia Nacional de Investigación e InnovaciónImaging learningHIVCapsid proteinAntiviral drug discoveryCiencias Médicas y de la SaludMedicina BásicaMedicina QuímicaCiencias Naturales y ExactasCiencias BiológicasBioquímica y Biología MolecularDiscovery of HIV capsid inhibitorsDocumento de conferenciaPublicadoinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectUniversidad de la República. CENUR Litoral Norte//Ciencias Médicas y de la Salud/Medicina Básica/Medicina Química//Ciencias Naturales y Exactas/Ciencias Biológicas/Bioquímica y Biología MolecularArtía, ZoraimaRandall, LíaCorvo, IleanaNuenen, AdKootstra, NeeltjeÁlvarez, GuzmánLICENSElicense.txtlicense.txttext/plain; charset=utf-84967https://redi.anii.org.uy/jspui/bitstream/20.500.12381/5284/2/license.txta4ce09f01b5dd771727aa05c73851623MD52ORIGINALPóster BrazMedChem 2022_ 120x90.pdfPóster BrazMedChem 2022_ 120x90.pdfapplication/pdf10605936https://redi.anii.org.uy/jspui/bitstream/20.500.12381/5284/1/P%c3%b3ster%20BrazMedChem%202022_%20120x90.pdf3d2ad3d2cad0e327593c966b75d4b5daMD5120.500.12381/52842025-11-17 14:28:58.634oai:redi.anii.org.uy:20.500.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Institucionalhttps://redi.anii.org.uy/Gobiernohttps://www.anii.org.uy/https://redi.anii.org.uy/oai/requestjmaldini@anii.org.uyUruguayopendoar:94212025-11-17T17:28:58REDI - Agencia Nacional de Investigación e Innovaciónfalse
spellingShingle Discovery of HIV capsid inhibitors
Artía, Zoraima
Imaging learning
HIV
Capsid protein
Antiviral drug discovery
Ciencias Médicas y de la Salud
Medicina Básica
Medicina Química
Ciencias Naturales y Exactas
Ciencias Biológicas
Bioquímica y Biología Molecular
status_str publishedVersion
title Discovery of HIV capsid inhibitors
title_full Discovery of HIV capsid inhibitors
title_fullStr Discovery of HIV capsid inhibitors
title_full_unstemmed Discovery of HIV capsid inhibitors
title_short Discovery of HIV capsid inhibitors
title_sort Discovery of HIV capsid inhibitors
topic Imaging learning
HIV
Capsid protein
Antiviral drug discovery
Ciencias Médicas y de la Salud
Medicina Básica
Medicina Química
Ciencias Naturales y Exactas
Ciencias Biológicas
Bioquímica y Biología Molecular
url https://hdl.handle.net/20.500.12381/5284
https://proceedings.science/brazmedchem-2022/papers/discovery-of-hiv-capsid-inhibitors?lang=en